Vitls wins at Texas A&M New Venture Competition
Houston, Texas, May 24, 2018 Vitls Inc., based locally here in Houston recently competed in the 2018 Texas A&M New Ventures Competition (TNVC) in College Station, Texas and was awarded the TMCx Investment Prize of $25,000 and the Paragon Engineering Services Prize of $10,000.
Vitls has developed the thinnest, most unobtrusive wearable available, that monitors a full suite of vital signs, giving care providers a real-time and complete image of a patient’s status. The company was started 2 years ago because the founders couldn’t find a way to remotely monitor their son who suffered from febrile seizures. They developed the technology and recently relocated to Houston, from South Africa, to prepare for a pilot with Texas Children’s Hospital. Vitls participated in the TMCx Medical Device program in 2017 and is currently participating in Dreamit Ventures’ Health program.
“We’ve heard a lot about the New Ventures Competition, but the organizers still managed to exceed our expectations. It was a well-organized event and the quality of participating companies was very high. We would like to thank the Texas Medical Centre’s Innovation Institute (TMCx) for the investment Prize as well as Paragon Innovations for the Engineering Services prize.” - Werner Vorster, Founder & CEO
“The companies that received awards at the 2018 Texas A&M New Ventures Competition have gone through multiple, rigorous rounds of vetting, coaching, and judging and are truly the best-of-the-best in the State of Texas. We know from 4 years of data that these companies will go on to raise more capital, create more jobs and generally make bigger positive impact on our lives with their technologies than their peers.”, said Chris Scotti, Chair of TNVC 2018.
About Vitls: (for more information visit www.vitlsinc.com)
Vitls has developed an innovative way to enable earlier detection of deterioration in hospital patients. 75% of all adverse events and preventable deaths in hospitals occur outside the ICU in unmonitored beds. Our revolutionary platform enables healthcare providers to continuously and remotely monitor a patient’s vital signs, reliably and undisturbed. Real-time monitoring leads to early detection of patient deterioration
which in turn reduces length of stay, treatment costs and re-admissions. It also improves patient outcomes and patient satisfaction scores.
We collect multi-parameter vital sign data with an innovative device that monitors body temperature, heart rate, RR interval, respiration rate, pulse ox (SpO2), movement (including fall detection) and sleep cycles. Our wearables are thin, unobtrusive, flexible, waterproof, have a 6-day battery life and are disposable. Think of it as an incredibly clever band-aid, packed full of technology and worn on the chest. We then send the data via our cloud database to a screen at the nurse’s station or any connected smart device.
About the Texas A&M New Ventures Competition: (for more information visit www.TexasNVC.org) Aimed at promoting the commercialization of emerging technology, TNVC recognizes companies with high-growth potential and provides seed funding to help them effectively execute their ideas and advance product development. The Texas A&M Engineering Experiment Station and The Texas A&M University System, along with a growing number of sponsors, are working to ensure today’s innovative ideas become a reality through the TNVC. More info at www.texasnvc.org